The document is an intimation of an Earnings Webinar for Jubilant Pharmova Limited, scheduled for Monday, November 16, 2026, from 08:30 AM to 09:30 AM IST.
The event is being organized pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The stated purpose is for the management to discuss the company's financial performance for the quarter and half year ended September 30, 2026 (Q2 and H1 FY27).
The webinar will commence with a brief management commentary on the financial performance, followed by an interactive Q&A session.
The presentation made during the event will be submitted to the stock exchanges before the event and hosted on the company website at www.jubilantpharmova.com.
The event is open to all investors, and pre-registration is mandatory via a provided Zoom link.
Additional Notes Section
The document includes an earnings webinar invitation with detailed registration instructions and time zone conversions (08:30 AM IST | 03:00 AM UK | 11:00 AM Singapore | 10:00 PM EST on Sunday, November 15).
No financial data or performance figures for Q2 and H1 FY27 are disclosed in this announcement.
Contact information for investor relations is provided: Pankaj Dhawan from Jubilant Pharmova and Runjhun Jain / Sneha Salian from EY Investor Relations.
A standard disclaimer regarding forward-looking statements is included at the end of the document.
